Peripheral Neuropathy Clinical Trials 2024

Peripheral Neuropathy Clinical Trials 2024

Peripheral Neuropathy research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in peripheral neuropathy clinical trials today.

Peripheral Neuropathy Clinical Trials

Here are the 6 most popular medical studies for peripheral neuropathy

Popular filter options for peripheral neuropathy trials

Diabetic Neuropathy Clinical Trials

View 70 Diabetic Neuropathy medical studies.

Peripheral Nerve Injury Clinical Trials

View 58 Peripheral Nerve Injury medical studies.

Peripheral Neuropathy Clinical Trials With No Placebo

View 98 peripheral neuropathy medical studies that do not have a placebo group.

View More Peripheral Neuropathy Trials

See another 73 medical studies focused on peripheral neuropathy.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to peripheral neuropathy

What are the top hospitals conducting peripheral neuropathy research?

Finding effective treatments for peripheral neuropathy, a condition characterized by nerve damage that often leads to pain and numbness in the extremities, is a pressing challenge. However, several renowned medical centers are stepping up to the plate with ongoing clinical trials. In Clermont, Florida, South Lake Pain Institute is at the forefront of research with three active trials focused on peripheral neuropathy. Although they have yet to conduct any previous studies in this field, their dedication to advancing knowledge and treatment options is commendable. Similarly dedicated is M D Anderson Cancer Center in Houston, which also has three ongoing trials dedicated specifically to peripheral neuropathy but lacks any past investigations recorded. The University of California in San Diego joins this pursuit as well and currently has two active clinical trials addressing peripheral neuropathy; similar to the other hospitals mentioned here it also hasn't conducted past activities related directly.Closer towards East Coast resides Mount Sinai School of Medicine located within New york City limits -where researchers are exploring innovative solutions through two existing clinical tests targeted specifically towards patients suffering fromperipheral neuropathic symptoms showing hopefulness spirit despite not having ventured into such explorations prior.All the way across the country at University of Washington Medical Center located within Seattle territory , there are additional efforts being made.They currently hold two active clinical attempts hopingto find breakthroughs while simultaneously creating a benchmark record since there haven't been any investigations conducted previously regarding these cases.

These medical institutions serve as beacons of hope for those living with peripheral neuropathy by actively seeking new ways to alleviate their symptoms and improve their quality of life.With each trial comes an opportunity for groundbreaking discoveries that could revolutionize how we approach and manage this complex condition nationwide.Locations might differ from one another geographically but unitedly represent commitment towards enhancing patient care on national scale

Which are the best cities for peripheral neuropathy clinical trials?

When it comes to peripheral neuropathy clinical trials, several cities have emerged as leading centers for research and development. Houston, Texas and Atlanta, Georgia both offer 10 active trials investigating treatments such as Engensis, Duloxetine, Docetaxel, and Transcutaneous Electrical Nerve Stimulation. New york City follows closely behind with 9 ongoing studies exploring options like NRD135SE.1 and VX-548. Additionally, Chicago in Illinois and Anchorage in Alaska each host 8 active trials focused on various treatment modalities including Brief Electrical Stimulation Therapy and Docetaxel. These cities provide individuals suffering from peripheral neuropathy access to cutting-edge clinical trials that are essential for advancing the field of neurology and improving patient outcomes.

Which are the top treatments for peripheral neuropathy being explored in clinical trials?

Clinical trials are paving the way for new treatments to combat peripheral neuropathy, a condition that affects the nerves outside of the brain and spinal cord. One promising contender in this arena is NTX-001. This innovative treatment is currently being explored in two active clinical trials dedicated specifically to peripheral neuropathy. Since its introduction in 2020, it has already made an impact with its inclusion in two all-time trials focused on this debilitating condition. As researchers delve deeper into understanding and addressing peripheral neuropathy, NTX-001 demonstrates potential as a game-changer in providing relief for those suffering from this nerve disorder.

What are the most recent clinical trials for peripheral neuropathy?

Recent clinical trials have shown promising advancements in the field of peripheral neuropathy, offering hope to those affected by this condition. One such trial investigated the use of fish oil concentrate in oral capsule form as a potential treatment option. The results from Phase 1 and Phase 2 trials have sparked enthusiasm within the medical community. Additionally, cryocompression therapy, tested through a Phase 3 trial known as Arm 1, has demonstrated encouraging outcomes for peripheral neuropathy patients. Another notable study explored the efficacy of NTX-001—a development that could potentially pave the way for new therapeutic approaches. Moreover, ATX01 10% has exhibited promise in its ability to alleviate symptoms associated with peripheral neuropathy during Phase 2 trials. Lastly, focal vibration therapy showcased positive responses throughout its initial phase of testing—indicating potential benefits for individuals suffering from this condition. With these recent advances in research and treatment modalities, prospects are brightening up for individuals managing peripheral neuropathy.

What peripheral neuropathy clinical trials were recently completed?

Recently completed clinical trials in peripheral neuropathy have made significant strides in the search for effective treatments. These studies focus on understanding and managing this condition that affects the nerves outside of the brain and spinal cord. Notably, a trial evaluating the efficacy of Nerve Growth Factor (NGF) inhibitors was recently concluded, offering potential new avenues for therapeutic intervention. Further advancements were seen in a trial investigating stem cell therapy as a possible treatment option. The completion of these innovative trials demonstrates ongoing efforts to alleviate the burden faced by individuals living with peripheral neuropathy and brings hope for improved management strategies in the future.